---
schema_version: "secwatch.filing_event.v1"
accession: "0001157523-23-000832"
form_type: "8-K/A"
ticker: "USNA"
cik: "0000896264"
company_name: "USANA HEALTH SCIENCES INC"
filed_at: "2023-05-12T23:59:59+00:00"
generated_at: "2026-06-15T03:14:43.022864+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# USANA CEO-to-be Jim Brown gets $800K base salary; Kevin Guest base cut to $750K as Executive Chair

## Summary
- Jim Brown's annual base salary as CEO increases from $627K to $800K effective July 1, 2023.
- Kevin Guest's base salary as Executive Chair reduces from $945K to $750K effective July 1, 2023.
- Both remain eligible for Executive Bonus Plan (Brown at 100% of base target, Guest at 50%).
- Both continue eligibility for equity grants under 2015 Plan, 401K, and medical benefits.
- Compensation approved by Compensation Committee on May 10, 2023; disclosed via 8-K/A amendment.

## SEC filing metadata
- accession: 0001157523-23-000832
- form_type: 8-K/A
- ticker: USNA
- cik: 0000896264
- company_name: USANA HEALTH SCIENCES INC
- filed_at: 2023-05-12T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/896264/000115752323000832/0001157523-23-000832-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/896264/000115752323000832/a53399029.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001157523-23-000832
- JSON: https://secwatch.observer/filing/0001157523-23-000832.json
- Plain text: https://secwatch.observer/filing/0001157523-23-000832.txt

## Key facts
- Executive change
  Jim Brown was appointed as Chief Executive Officer at USANA HEALTH SCIENCES INC.
  - Action: appointed
  - Role: Chief Executive Officer
  source text: its Board of Directors (the “Board”) appointed Jim Brown as the Company’s Chief Executive Officer effective July 1, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/896264/000115752323000832/0001157523-23-000832-index.htm
- Executive change
  Kevin Guest changed role as Executive Chairman at USANA HEALTH SCIENCES INC.
  - Action: transitioned
  - Role: Executive Chairman
  source text: Mr. Brown will succeed Kevin Guest, who will transition to Executive Chairman of the Company on the Effective Date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/896264/000115752323000832/0001157523-23-000832-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.